JPRN-UMIN000001614CompletedPhase 2
Multicenter phase II study of second-line S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancer - Phase II study of S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancer
Faculty of Medicine, University of Tokyo0 sites22 target enrollmentStarted: January 3, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 22
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Patients with an active concomitant infection 2) Patients with digestive ulcer or gastrointestinal bleeding 3) Patients with severe cardiovascular or renal disease 4) Patients with uncontrollable massive pleural effusion or massive ascites 5) Patients with an active concomitant malignancy 6) Pregnant, lactating female and patients of reproductive potential who did not use effective contraception 7) Patients with a previous history of a severe drug hypersensitivity 8) Patients receiving anti-cancer drugs 9) Inappropriate patients for entry on this study in the judgement of the investigator
Investigators
Similar Trials
Completed
Phase 2
A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancerJPRN-UMIN000007386Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine28
Completed
Phase 2
Multicenter phase II study of oral S-1 monotherapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapiesColorectal cancerJPRN-UMIN000006487Chube Clinical Oncology Group (CCOG)34
Recruiting
Phase 2
Phase II study of S-1 monotherapy as 1st line chemotherapy in patients > or = 80 with advanced non-small cell lung cancerpatients >or = 80 with advanced non-small cell lung cancerJPRN-UMIN000008490Shinshu University Hospital35
Active, not recruiting
Not Applicable
Study of a new drug combination to treat Chronic Lymphocytic Leukemiantreated or Relapsed Chronic Lymphocytic LeukaemiaMedDRA version: 14.1Level: LLTClassification code 10008968Term: Chronic lymphocytic leukaemia stage A(0)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005178-43-ITGLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.80
Completed
Phase 2
Multicenter phase II study of S-1 plus Weekly Cisplatin in first-line treatment of unresectable or reccurent gastric cancergastric cancerJPRN-UMIN000001858Tsukuba Cancer Clinical Trial Group70